Whole-genome analysis reveals the contribution of non-coding de novo transposon insertions to autism spectrum disorder
Abstract Background Retrotransposons have been implicated as causes of Mendelian disease, but their role in autism spectrum disorder (ASD) has not been systematically defined, because they are only called with adequate sensitivity from whole genome sequencing (WGS) data and a large enough cohort for...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8f9cee324ba7466e90e75f9ca6ee92f3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:8f9cee324ba7466e90e75f9ca6ee92f3 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:8f9cee324ba7466e90e75f9ca6ee92f32021-11-28T12:22:13ZWhole-genome analysis reveals the contribution of non-coding de novo transposon insertions to autism spectrum disorder10.1186/s13100-021-00256-w1759-8753https://doaj.org/article/8f9cee324ba7466e90e75f9ca6ee92f32021-11-01T00:00:00Zhttps://doi.org/10.1186/s13100-021-00256-whttps://doaj.org/toc/1759-8753Abstract Background Retrotransposons have been implicated as causes of Mendelian disease, but their role in autism spectrum disorder (ASD) has not been systematically defined, because they are only called with adequate sensitivity from whole genome sequencing (WGS) data and a large enough cohort for this analysis has only recently become available. Results We analyzed WGS data from a cohort of 2288 ASD families from the Simons Simplex Collection by establishing a scalable computational pipeline for retrotransposon insertion detection. We report 86,154 polymorphic retrotransposon insertions—including > 60% not previously reported—and 158 de novo retrotransposition events. The overall burden of de novo events was similar between ASD individuals and unaffected siblings, with 1 de novo insertion per 29, 117, and 206 births for Alu, L1, and SVA respectively, and 1 de novo insertion per 21 births total. However, ASD cases showed more de novo L1 insertions than expected in ASD genes. Additionally, we observed exonic insertions in loss-of-function intolerant genes, including a likely pathogenic exonic insertion in CSDE1, only in ASD individuals. Conclusions These findings suggest a modest, but important, impact of intronic and exonic retrotransposon insertions in ASD, show the importance of WGS for their analysis, and highlight the utility of specific bioinformatic tools for high-throughput detection of retrotransposon insertions.Rebeca Borges-MonroyChong ChuCaroline DiasJaejoon ChoiSoohyun LeeYue GaoTaehwan ShinPeter J. ParkChristopher A. WalshEunjung Alice LeeBMCarticleTransposable elementsRetrotransposonsAutism spectrum disorderde novo insertionsPolymorphic insertionsde novo ratesGeneticsQH426-470ENMobile DNA, Vol 12, Iss 1, Pp 1-15 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Transposable elements Retrotransposons Autism spectrum disorder de novo insertions Polymorphic insertions de novo rates Genetics QH426-470 |
spellingShingle |
Transposable elements Retrotransposons Autism spectrum disorder de novo insertions Polymorphic insertions de novo rates Genetics QH426-470 Rebeca Borges-Monroy Chong Chu Caroline Dias Jaejoon Choi Soohyun Lee Yue Gao Taehwan Shin Peter J. Park Christopher A. Walsh Eunjung Alice Lee Whole-genome analysis reveals the contribution of non-coding de novo transposon insertions to autism spectrum disorder |
description |
Abstract Background Retrotransposons have been implicated as causes of Mendelian disease, but their role in autism spectrum disorder (ASD) has not been systematically defined, because they are only called with adequate sensitivity from whole genome sequencing (WGS) data and a large enough cohort for this analysis has only recently become available. Results We analyzed WGS data from a cohort of 2288 ASD families from the Simons Simplex Collection by establishing a scalable computational pipeline for retrotransposon insertion detection. We report 86,154 polymorphic retrotransposon insertions—including > 60% not previously reported—and 158 de novo retrotransposition events. The overall burden of de novo events was similar between ASD individuals and unaffected siblings, with 1 de novo insertion per 29, 117, and 206 births for Alu, L1, and SVA respectively, and 1 de novo insertion per 21 births total. However, ASD cases showed more de novo L1 insertions than expected in ASD genes. Additionally, we observed exonic insertions in loss-of-function intolerant genes, including a likely pathogenic exonic insertion in CSDE1, only in ASD individuals. Conclusions These findings suggest a modest, but important, impact of intronic and exonic retrotransposon insertions in ASD, show the importance of WGS for their analysis, and highlight the utility of specific bioinformatic tools for high-throughput detection of retrotransposon insertions. |
format |
article |
author |
Rebeca Borges-Monroy Chong Chu Caroline Dias Jaejoon Choi Soohyun Lee Yue Gao Taehwan Shin Peter J. Park Christopher A. Walsh Eunjung Alice Lee |
author_facet |
Rebeca Borges-Monroy Chong Chu Caroline Dias Jaejoon Choi Soohyun Lee Yue Gao Taehwan Shin Peter J. Park Christopher A. Walsh Eunjung Alice Lee |
author_sort |
Rebeca Borges-Monroy |
title |
Whole-genome analysis reveals the contribution of non-coding de novo transposon insertions to autism spectrum disorder |
title_short |
Whole-genome analysis reveals the contribution of non-coding de novo transposon insertions to autism spectrum disorder |
title_full |
Whole-genome analysis reveals the contribution of non-coding de novo transposon insertions to autism spectrum disorder |
title_fullStr |
Whole-genome analysis reveals the contribution of non-coding de novo transposon insertions to autism spectrum disorder |
title_full_unstemmed |
Whole-genome analysis reveals the contribution of non-coding de novo transposon insertions to autism spectrum disorder |
title_sort |
whole-genome analysis reveals the contribution of non-coding de novo transposon insertions to autism spectrum disorder |
publisher |
BMC |
publishDate |
2021 |
url |
https://doaj.org/article/8f9cee324ba7466e90e75f9ca6ee92f3 |
work_keys_str_mv |
AT rebecaborgesmonroy wholegenomeanalysisrevealsthecontributionofnoncodingdenovotransposoninsertionstoautismspectrumdisorder AT chongchu wholegenomeanalysisrevealsthecontributionofnoncodingdenovotransposoninsertionstoautismspectrumdisorder AT carolinedias wholegenomeanalysisrevealsthecontributionofnoncodingdenovotransposoninsertionstoautismspectrumdisorder AT jaejoonchoi wholegenomeanalysisrevealsthecontributionofnoncodingdenovotransposoninsertionstoautismspectrumdisorder AT soohyunlee wholegenomeanalysisrevealsthecontributionofnoncodingdenovotransposoninsertionstoautismspectrumdisorder AT yuegao wholegenomeanalysisrevealsthecontributionofnoncodingdenovotransposoninsertionstoautismspectrumdisorder AT taehwanshin wholegenomeanalysisrevealsthecontributionofnoncodingdenovotransposoninsertionstoautismspectrumdisorder AT peterjpark wholegenomeanalysisrevealsthecontributionofnoncodingdenovotransposoninsertionstoautismspectrumdisorder AT christopherawalsh wholegenomeanalysisrevealsthecontributionofnoncodingdenovotransposoninsertionstoautismspectrumdisorder AT eunjungalicelee wholegenomeanalysisrevealsthecontributionofnoncodingdenovotransposoninsertionstoautismspectrumdisorder |
_version_ |
1718408028147941376 |